ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2032

Effector T Helper Cell Differentiation and Cytokine Secretion Are Increased in Young Children with Juvenile Idiopathic Arthritis

Anna Patrick1, Thomas Aune2, Jessica Duis3 and T. Brent Graham4, 1Pediatric Rheumatology, Monroe Carell Junior Children's Hospital at Vanderbilt, Division of Pediatric Rheumatology, Nashville, TN, 2Medicine, Vanderbilt University Medical Center, Division of Rheumatology, Nashville, TN, 3Pediatrics, Monroe Carell Junior Children's Hospital at Vanderbilt, Division of Medical Genetics and Genomic Medicine, Nashville, TN, 4Pediatrics, Monroe Carell Junior Children's Hospital at Vanderbilt, Division of Pediatric Rheumatology, Nashville, TN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA) and pediatric rheumatology, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

T cells play a critical role in the body’s response to pathogens. A naïve T helper (Th0) cell proliferates in response to antigen encounter and is not differentiated. Specific cytokines signal the naive Th cell to express transcription factors causing differentiation to Th cell lineages, including Th1, Th2, and Th17 lines. Re-activation causes a differentiated effector Th cell to secrete characteristic cytokines, which are IFNγ, IL-5 and IL-13, and IL-17 for Th1, Th2, and Th17 cells respectively. In juvenile idiopathic arthritis (JIA), specific Th cell lineage differentiation and cytokine secretion have not been studied. An ex vivo assay was developed in adult human peripheral blood mononuclear cells (pBMCs) wherein mononuclear cells differentiate, re-activate, and then secrete cytokines. We identified a young child with JIA who has a heterozygous mutation in GATA-3, the key transcription factor that drives the Th2 pathway and suppresses the Th1 and Th17 pathways (index patient). In this study, we tested effector Th cell differentiation and cytokine secretion in pBMCs from young children, young children with JIA, and the index patient.

Methods: We enrolled healthy controls, children with seronegative polyarticular or extended oligoarticular JIA, and the index patient. All children were 2-8 years old. PBMCs underwent collection, ex vivo differentiation to Th0, Th1, Th2, and Th17 cells, and then re-stimulation. After this, cytokine secretion was measured by enzyme-linked immunosorbent assay. Transcription factor expression and cytokine transcription was assessed by Western blot and quantitative real time polymerase chain reaction. Whole exome sequencing identified the index patient GATA-3 mutation.

Results: Differentiated effector Th cell cultures from children with JIA secrete much higher levels of characteristic cytokines than healthy control children. The Th cell average JIA/control ratios were markedly increased for Th1 (IFNγ, 3.4), Th2 (IL-5, 6.0 and IL-13, 10.3), and Th17 (IL-17, 5.5). The index patient had increased index/control ratios for Th1 (IFNγ, 4.5) and Th17 (IL-17, 3.6) cultures and no change in Th-2 ratios. Surprisingly, the undifferentiated Th0 cells from children with JIA and the index patient secrete IFNγ, with ratios being JIA/control 5.5 and index/control 22.6. The ex vivo assay in healthy children produces much lower levels of cytokines than in healthy adults.

Conclusion: Young children produce differentiated effector Th cells that make much less cytokines than adult differentiated effector Th cells. Cultures from children with JIA make more cytokines than cultures from healthy children and are similar to adult cultures. The index patient does not produce differentiated Th2 cells that secrete IL-13 and IL-5, as might be predicted from a GATA-3 mutation. Both the JIA and index patient undifferentiated Th0 cell cultures secrete IFNγ, suggesting a Th1-like phenotype. Mechanisms underlying differences between effector Th cell cultures from young children, children with JIA, the index patient, and adults may reveal fundamental differences in these developmental processes, including limits on the function of the immune system in young children.


Disclosure: A. Patrick, None; T. Aune, None; J. Duis, None; T. B. Graham, None.

To cite this abstract in AMA style:

Patrick A, Aune T, Duis J, Graham TB. Effector T Helper Cell Differentiation and Cytokine Secretion Are Increased in Young Children with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/effector-t-helper-cell-differentiation-and-cytokine-secretion-are-increased-in-young-children-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effector-t-helper-cell-differentiation-and-cytokine-secretion-are-increased-in-young-children-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology